Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Supriya Lifescience Limited (NSE: SUPRIYA), ISIN INE07RO01027 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUPRIYA last traded at ₹636.30 (-8.55%), with a 52-week range of ₹545.50 to ₹1085.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 68.30%, FIIs 6.45%, DIIs 5.47%, mutual funds 1.28%.
EquiSense Score (ECS): 49/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.